ARGX technical analysis
ARGX Technical Analysis
Analysis date
July 15, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 14, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
ARGX Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- ARGX
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 14, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 907.82 | July 14, 2026 | - | Verified |
| Finviz (independent) | 907.82 | July 14, 2026 (previous close) | 0.00% | Verified |
Bottom line
ARGX Technical Analysis Summary
ARGX (argenx SE) shows a mixed technical picture with the daily chart displaying constructive short-term momentum while the weekly structure still reflects a consolidation phase. On the daily chart, price at 907.82 is above SMA20 (878.83) and SMA50 (863.67) but remains below SMA200 (939.45), indicating the stock has not yet reclaimed its long-term moving average. RSI14 at 54.66 on the daily chart sits above the 50 midline, reflecting bullish but not overbought momentum. The daily MACD shows the MACD line at 1.87 above the signal line at 0.10 with a positive histogram of 1.77 — a bullish configuration suggesting improving short-term momentum. On the weekly timeframe, price at 902.30 is below SMA20 (932.41) and SMA50 (982.17), with RSI at 49.01 sitting just below the 50 midline, reflecting neutral-to-slightly-bearish weekly momentum. Key resistance lies at the 60-day high of 948.24 and SMA200 at 939.45. Support rests at 856.33 (20-day low) and 814.76 (60-day low). A sustained move above 948.24 would be needed to challenge the longer-term SMA200 and shift the outlook more decisively bullish.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 14, 2026)
- Trend
- Improving but incomplete. Price at 907.82 is above SMA20 (878.83, +3.30%) and SMA50 (863.67, +5.11%) but below SMA200 (939.45, -3.37%). The SMA20 is sloping upward and the SMA50 has started to flatten, while SMA200 continues to decline gradually. This configuration suggests the short-term trend has improved but the stock has not yet broken out of its longer-term consolidation.
- Momentum
- Modestly bullish. RSI14 at 54.66 is above the 50 midline, indicating bullish bias without reaching overbought territory. MACD line at 1.87 is above the signal line at 0.10, and the histogram at 1.77 is positive — a bullish crossover that has been in place for multiple sessions. This suggests momentum is tilted in favor of the bulls on the daily timeframe.
- Volatility
- Moderate. ATR14 at 20.14 (2.22% of price) suggests average daily movement of about 2.2%. Bollinger Bands (839.73 to 956.49) show price near the middle of the band, consistent with the current range-bound behavior. Band width is moderate, reflecting normal volatility conditions for a mid-cap biotech.
- Volume
- Below average. Latest volume of 344,500 is 69.8% of the 20-period average (493,600), indicating reduced participation. The recent recovery lacks strong volume confirmation, which tempers conviction in the bullish view.
Assessment
The daily chart presents a cautiously constructive picture. ARGX has reclaimed both SMA20 and SMA50 after spending time below them, and the MACD bullish crossover is a technically positive signal. However, price remains below the declining SMA200, and volume has been below average during the recovery. The stock is in a broad consolidation range between roughly 815 and 950. A decisive move above the 60-day high at 948.24 and SMA200 at 939.45 would signal a potential breakout from this range.
Weekly (July 6, 2026 week)
- Trend
- Neutral-to-bearish. Price at 902.30 is below SMA20 (932.41) and SMA50 (982.17). The SMA20 has flattened after declining, suggesting the weekly downtrend from the 2025 highs above 1,100 may be stabilizing. SMA50 continues to slope downward, confirming the medium-term trend is still under pressure.
- Momentum
- Neutral. RSI14 at 49.01 is essentially at the 50 midline, reflecting balanced momentum. MACD line at -23.87 is below the signal line at -21.46, and the histogram at -2.41 is negative — a bearish configuration though the gap is narrowing, suggesting bearish momentum is fading.
- Volatility
- Moderate. ATR14 at 40.98 (4.54% of price) reflects typical weekly ranges for a mid-cap biotech stock with binary event risk (FDA decisions, trial data). Bollinger Bands (807.89 to 1,041.31) are wide, reflecting the stock's historical volatility range.
- Volume
- Near average. Weekly volume of 2,021,800 is 88.5% of the 20-week average (2,285,000), indicating typical participation levels.
Assessment
The weekly chart reflects a stock in a consolidation phase after the decline from the 2025 highs above 1,100. Price remains below both SMA20 and SMA50, but the flattening of SMA20 and the narrowing MACD suggest the downtrend is losing momentum. RSI hovering near 50 reflects equilibrium between buyers and sellers. A weekly close above SMA20 (932.41) would be the first step toward trend improvement. The stock appears to be building a base in the 810-950 range, with the next major catalyst likely determining the direction of the next sustained move.
Key indicators
ARGX Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 54.66 | 49.01 |
| MACD (12, 26, 9) | 1.87 / 0.10 / 1.77 | -23.87 / -21.46 / -2.41 |
| ATR (14) | 20.14 (2.22%) | 40.98 (4.54%) |
| Bollinger Bands (20, 2) | 839.73 - 956.49 | 807.89 - 1,041.31 |
| SMA (20) | 878.83 | 932.41 |
| SMA (50) | 863.67 | 982.17 |
| SMA (200) | 939.45 | -- |
Price structure
ARGX Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 907.82 | 902.30 |
| 1-Period Return | +1.03% | +2.01% |
| 5-Period Return | +0.91% | +3.75% |
| 20-Period Return | +4.12% | -0.18% |
| 60-Period Return | +9.54% | -4.82% |
| 252-Period Return | -4.18% | -12.36% |
| 52-Week Low | 601.05 | 601.05 |
| 52-Week High | 1,141.99 | 1,141.99 |
| 52-Week Position | 51.33% | 50.55% |
Key levels
ARGX Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 956.49 | 997.65 |
| 20-Period Low | 856.33 | 837.52 |
| 60-Period High | 948.24 | 1,141.99 |
| 60-Period Low | 814.76 | 601.05 |
Scenarios
ARGX Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price breaks above the 60-day high at 948.24 and SMA200 at 939.45 on above-average volume, establishing a breakout from the consolidation range.
Invalidation
Price falls back below SMA20 (878.83) and breaks the 20-day low at 856.33.
What to watch
Daily RSI holding above 55; MACD histogram continuing to expand; volume increasing on break attempts; weekly RSI crossing above 50.
Range-Bound
Trigger
Price oscillates between SMA20 support (878.83) and the 948-956 resistance zone with no clear directional bias.
Invalidation
A decisive break above 956.49 or below 856.33 with increasing volume.
What to watch
RSI staying between 45 and 60; MACD histogram fluctuating around zero; volume remaining near average levels; no strong catalyst emerging.
Bearish
Trigger
Price fails to hold above SMA50 (863.67) and breaks below the 20-day low at 856.33, resuming the longer-term downtrend from the 2025 highs.
Invalidation
Price reclaims and holds above SMA20 (878.83) and establishes a higher low above 856.33.
What to watch
Daily RSI falling below 50; MACD histogram turning negative; volume increasing on down days; SMA20 crossing below SMA50.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.